Moore Capital Management’s Oaktree Acquisition Corp III Life Sciences Warrant OACCW Stock Holding History
Bought
Maintained
Sold
Other funds holding OACCW
Moore Capital Management's OACCW Position: Q3 2026 in Review
Moore Capital Management held its Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) position steady in Q3 2026 at 105,000 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #521.
Moore Capital Management first reported a position in OACCW in Q2 2025 and has held it in 6 quarters since. 25 funds tracked by Wall St. Rank hold OACCW as of Q3 2026.
- Moore Capital Management held 105,000 shares of Oaktree Acquisition Corp III Life Sciences Warrant worth $105K as of Q3 2026.
- Moore Capital Management left its Oaktree Acquisition Corp III Life Sciences Warrant share count unchanged in Q3 2026.
- Oaktree Acquisition Corp III Life Sciences Warrant made up ﹤0.01% of Moore Capital Management's portfolio in Q3 2026, its #521 holding.
- Moore Capital Management first reported a position in Oaktree Acquisition Corp III Life Sciences Warrant in Q2 2025 and has held it in 6 quarters since.
- 25 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Warrant as of Q3 2026.
Based on Moore Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.